Lipid Binding Sites Research Articles

Crystal Structure of the ORP8 Lipid Transport ORD Domain: Model of Lipid Transport.

ORPs are lipid-transport proteins belonging to the oxysterol-binding protein family. They facilitate the transfer of lipids between different intracellular membranes, such as the ER and plasma membrane. We have solved the crystal structure of the ORP8 lipid transport domain (ORD8). The ORD8 exhibited a β-barrel fold composed of anti-parallel β-strands, with three α-helices replacing β-strands on one side. This mixed alpha-beta structure was consistent with previously solved structures of ORP2 and ORP3. A large cavity (≈1860 Å3) within the barrel was identified as the lipid-binding site. Although we were not able to obtain a lipid-bound structure, we used computer simulations based on our crystal structure to dock PS and PI4P molecules into the putative lipid-binding site of the ORD8. Comparative experiments between the short ORD8ΔLid (used for crystallography) and the full-length ORD8 (lid containing) revealed the lid's importance for stable lipid binding. Fluorescence assays revealed different transport efficiencies for PS and PI4P, with the lid slowing down transport and stabilizing cargo. Coarse-grained simulations highlighted surface-exposed regions and hydrophobic interactions facilitating lipid bilayer insertion. These findings enhance our comprehension of ORD8, its structure, and lipid transport mechanisms, as well as provide a structural basis for the design of potential inhibitors.

Evolutionary Implications from Lipids in Membrane Bilayers and Photosynthetic Complexes in Cyanobacteria and Chloroplasts.

In biomembranes, lipids form bilayer structures that serve as the fluid matrix for membrane proteins and other hydrophobic compounds. Additionally, lipid molecules associate with membrane proteins and impact their structures and functions. In both cyanobacteria and the chloroplasts of plants and algae, the lipid bilayer of the thylakoid membrane consists of four distinct glycerolipid classes: monogalactosyldiacylglycerol, digalactosyldiacylglycerol, sulfoquinovosyldiacylglycerol, and phosphatidylglycerol. These lipids are also integral components of photosynthetic complexes such as photosystem II and photosystem I. The lipid binding sites within the photosystems, as well as the lipid composition in the thylakoid membrane, are highly conserved between cyanobacteria and photosynthetic eukaryotes, and each lipid class has specific roles in oxygenic photosynthesis. This review aims to shed light on the potential evolutionary implications of lipid utilization in membrane lipid bilayers and photosynthetic complexes in oxygenic photosynthetic organisms.

The solute carrier SPNS2 recruits PI(4,5)P2 to synergistically regulate transport of sphingosine-1-phosphate

Solute carrier spinster homolog 2 (SPNS2), one of only four known major facilitator superfamily (MFS) lysolipid transporters in humans, exports sphingosine-1-phosphate (S1P) across cell membranes. Here, we explore the synergistic effects of lipid binding and conformational dynamics on SPNS2's transport mechanism. Using mass spectrometry, we discovered that SPNS2 interacts preferentially with PI(4,5)P2. Together with functional studies and molecular dynamics (MD) simulations, we identified potential PI(4,5)P2 binding sites. Mutagenesis of proposed lipid binding sites and inhibition of PI(4,5)P2 synthesis reduce S1P transport, whereas the absence of the N terminus renders the transporter essentially inactive. Probing the conformational dynamics of SPNS2, we show how synergistic binding of PI(4,5)P2 and S1P facilitates transport, increases dynamics of the extracellular gate, and stabilizes the intracellular gate. Given that SPNS2 transports a key signaling lipid, our results have implications for therapeutic targeting and also illustrate a regulatory mechanism for MFS transporters.

MOLECULAR DYNAMICS SIMULATION OF THE CONFORMATIONAL MOBILITY OF THE LIPID-BINDING SITE IN THE APOLIPOPROTEIN E ISOFORMS Ε2, Ε3, AND Ε4

Neurodegenerative disorders, particularly Alzheimer’s disease, have become a major healthcare issue all over the world. Despite extensive research, the molecular mechanisms underlying these conditions are yet to be identi ed. APOE is the apolipoprotein E-coding gene. Its polymorphisms have been found to be signi cantly associated with both neurodegenerative disorders (rs429358, C112R) and protective e ects against these disorders (rs7412, R158C). Humans carry three apolipoprotein E isoforms: ε2 (protein with a protective mutation), ε3 (wild-type protein), and ε4 (protein with a pathogenic mutation). The study sought to investigate how these substitutions a ect the lipid-binding site, which is the functional region of the protein. Molecular dynamics simulation was used to analyze all three isoforms. We found that, unlike the wild-type isoform, both the pathogenic and protective mutations caused changes in the lipid-binding site. The changes, however, were di erent. Both ε2 and ε4 lead to an increased distance between the N-terminal (amino acids 88-104) and the C-terminal (amino acids 251-266) helices. However, in ε2, the C-terminal helix retained its structure, whereas in ε4, it unwound between amino acids 260 and 266. The opposite was true for the N-terminal helix. It is safe to assume that it is these structural di erences in the lipid-binding site that account for the di erent e ects of these two isoforms and clinical characteristics of their carriers. The clustering analysis allowed for the identi cation of the structures, most typical of ε2 and ε4, which could be used as the foundation for further molecular dynamics studies.

Molecular Dynamics Simulation of the Conformational Mobility of the Lipid-Binding Site in the Apolipoprotein E Isoforms ε2, ε3, and ε4

Molecular Dynamics Simulation of the Conformational Mobility of the Lipid-Binding Site in the Apolipoprotein E Isoforms ε2, ε3, and ε4

All-atoms molecular dynamics study to screen potent efflux pump inhibitors against KpnE protein of Klebsiella pneumoniae

The Small Multidrug Resistance efflux pump protein KpnE, plays a pivotal role in multi-drug resistance in Klebsiella pneumoniae. Despite well-documented study of its close homolog, EmrE, from Escherichia coli, the mechanism of drug binding to KpnE remains obscure due to the absence of a high-resolution experimental structure. Herein, we exclusively elucidate its structure-function mechanism and report some of the potent inhibitors through drug repurposing. We used molecular dynamics simulation to develop a dimeric structure of KpnE and explore its dynamics in lipid-mimetic bilayers. Our study identified both semi-open and open conformations of KpnE, highlighting its importance in transport process. Electrostatic surface potential map suggests a considerable degree of similarity between KpnE and EmrE at the binding cleft, mostly occupied by negatively charged residues. We identify key amino acids Glu14, Trp63 and Tyr44, indispensable for ligand recognition. Molecular docking and binding free energy calculations recognizes potential inhibitors like acarbose, rutin and labetalol. Further validations are needed to confirm the therapeutic role of these compounds. Altogether, our membrane dynamics study uncovers the crucial charged patches, lipid-binding sites and flexible loop that could potentiate substrate recognition, transport mechanism and pave the way for development of novel inhibitors against K. pneumoniae. Communicated by Ramaswamy H. Sarma

Endocannabinoids enhance hKV7.1/KCNE1 channel function and shorten the cardiac action potential and QT interval.

Genotype-positive patients who suffer from the cardiac channelopathy Long QT Syndrome (LQTS) may display a spectrum of clinical phenotypes, with often unknown causes. Therefore, there is a need to identify factors influencing disease severity to move towards an individualized clinical management of LQTS. One possible factor influencing the disease phenotype is the endocannabinoid system, which has emerged as a modulator of cardiovascular function. In this study, we aim to elucidate whether endocannabinoids target the cardiac voltage-gated potassium channel KV7.1/KCNE1, which is the most frequently mutated ion channel in LQTS. We used two-electrode voltage clamp, molecular dynamics simulations and the E4031 drug-induced LQT2 model of ex-vivo guinea pig hearts. We found a set of endocannabinoids that facilitate channel activation, seen as a shifted voltage-dependence of channel opening and increased overall current amplitude and conductance. We propose that negatively charged endocannabinoids interact with known lipid binding sites at positively charged amino acids on the channel, providing structural insights into why only specific endocannabinoids modulate KV7.1/KCNE1. Using the endocannabinoid ARA-S as a prototype, we show that the effect is not dependent on the KCNE1 subunit or the phosphorylation state of the channel. In guinea pig hearts, ARA-S was found to reverse the E4031-prolonged action potential duration and QT interval. We consider the endocannabinoids as an interesting class of hKV7.1/KCNE1 channel modulators with putative protective effects in LQTS contexts. ERC (No. 850622), Canadian Institutes of Health Research, Canada Research Chairs and Compute Canada, Swedish National Infrastructure for Computing.

Cardiomyocyte sarcolemma modelling and lipid-protein interactions.

The cardiomyocyte sarcolemma is a crucial cellular organelle in heart function. The vital components of the sarcolemma are membrane proteins that generate and control the cardiac action potential, responsible for cardiomyocyte contractibility and heart rhythm. Their malfunction can be caused by congenital mutations and side effects of antiarrhythmic therapies and can lead to life-threatening conditions related to heart failure. Other main components are represented by several lipid types, which not only provide the matrix for membrane proteins but also play active roles in regulating protein function. Shifts in membrane physiology through changes in the lipidomic profile or lipid-protein interactions can also cause cardiac disorders. Our goal is to characterize specific lipid-protein interactions in the sarcolemma by studying lipid redistribution around proteins and identifying lipid binding sites that can potentially regulate protein function. We combined lipidomic, cryo-electron microscopy and X-ray crystallography studies to build computational models of the cardiomyocyte sarcolemma. The membrane models consist of 16 lipid species, which differ in headgroup type, levels of acyl tail unsaturation and length. We embedded a selected membrane protein (cardiac ion channel, transporter or receptor) in a lipid bilayer and performed molecular dynamics simulations with the Martini coarse-grained models. We simulated each system with a corresponding membrane protein for 120 μs and analyzed lipid-protein interactions in terms of lipid redistribution around the proteins via computing lipid depletion-enrichment index, lipid density, and predicting lipid binding sites.Our results reproduce experimental findings of the interactions between lipids and the Kir2.2 potassium channel. We propose potential lipid binding sites for other proteins, highlighting similarities and differences in lipid redistribution and interaction with the cardiomyocyte proteins. Such findings unveil new possible lipid-protein interactions in the cardiomyocyte sarcolemma and provide an understanding of their relevance in heart function.

Absolute binding affinities of phospholipids to Erwinia ligand-gated ion channel (ELIC) by streamlined alchemical free energy perturbations (SAFEP).

An increasing number of cryo-EM structures of membrane proteins contain putative lipid binding sites with partially resolved lipid densities. In principle, these densities might be identified by computing the binding free energies of candidate ligands by alchemical free energy perturbation (FEP). In practice, however, these systems have several challenging features including lipid flexibility, system heterogeneity, and low binding affinity. Each of these confounds the distinction between the bound and unbound state: flexible molecules have large accessible volumes in conformation space; heterogeneous environments complicate the unbound state; and open, low-affinity sites mean that a “bound” ligand may still have considerably higher entropy than more in a more traditional, high-affinity binding pocket. Our SAFEP method seeks to address these problems by defining a single collective variable to define the bound state. This distance-from-bound configuration (DBC) metric reliably classifies ligand-protein conformations as “bound” or “unbound.” SAFEP has been successfully applied to the computation of absolute binding affinities of cholesterol to three GPCRs and relative binding affinities of phospholipids to two mutants of ELIC based on structural data. We have extended SAFEP to the calculation of absolute binding affinities of phospholipids. This has required additional sampling of each state and refinement to the collective variables used, especially in the unbound state. While this is somewhat more computationally expensive than computing relative free energies, absolute affinities make functional questions more accessible and mitigate the error propagation inherent to relative binding affinities. It is our hope that these methods will aid in the interpretation of similar systems.

Towards all-atoms sampling of membrane configurations using non-equilibrium molecular dynamics.

In all-atoms simulations, phenomena that can be observed are limited in terms of time-scale, usually up to a few µs. This means that slow processes taking place on a longer time-scale are not observable. Here, we develop a method to generate all-atoms configurations of membrane. The diffusion of the lipids within the membrane is not simulated per say, but non-equilibrium molecular dynamics is used to exchange the positions of the lipids in the membrane. With Monte-Carlo exchanges performed with alchemical transformation, different possible configurations of the membrane at the thermodynamic equilibrium are generated. It becomes possible to perform an equilibration of the membrane in all-atoms representations at a reduced sampling cost, and thus get a more precise model of the membrane organization. This algorithm could also be employed to decipher specific lipid binding sites modulating the function on membrane proteins

Identification and characterisation of lipids that are positive allosteric modulators of glycine receptors.

Glycine receptors are ligand-gated ion channels that mediate fast inhibitory neurotransmission within the nervous system. They have recently emerged as targets for chronic pain therapies due to their role in nociceptive signalling. N-arachidonyl glycine is an endogenous lipid that modulates glycine receptors, however its mechanism of action remains unclear. We have identified a series of N-acyl amino acids that positively modulate glycine receptors. From this, a second series of lipids containing a phenylene-moiety within the lipid tail were synthesised. This improved their efficacy by up to 6-fold, and increased the potency of receptor activation by over 10-fold. (8-2-octylphneyl)octanoyl)glycine (OPOG) had the greatest activity - potentiating the glycine EC5 by 1500% with an EC50 of 664 nM at the α1 receptor. OPOG was also found to be analgesic and produces a dose-dependent reversal of allodynia in rodent models of neuropathic pain. The second aim of this study was to identify lipid binding sites on the glycine receptor. Molecular dynamic simulations of OPOG at the α1 receptor were conducted and indicated consistent binding within a cavity at the intracellular portion of transmembrane domains (TM) 1 and 4. This site has previously been suggested to bind neurosteroids. A cryoEM structure of OPOG bound to the zebrafish glycine receptor was also obtained and identified binding to an inter-subunit cavity between the extracellular portions of TM1(-), TM2(+) and TM3(+). This cavity has previously been shown to bind the positive allosteric modulator ivermectin. Mutagenesis of the residues identified within the two sites was indicated potentiation occurs primarily through the neurosteroid binding site involving aromatic and positively charged residues. Further studies are required to explore binding within the ivermectin cavity and its relative contribution to lipid modulation.

Discovery of lipid binding sites in the ligand-gated ion channel GLIC through simulations and Cryo-EM.

Ligand-gated ion channels play an important role in electrochemical signal transduction in neurons and other excitable cells. Aside from canonical ligands, phospholipids have been shown to bind specifically and sometimes modulate several types of channels, but the structural details of such protein-lipid interactions remain unclear. Here, we present multiple lipid interaction sites in the pentameric ligand-gated ion channel, GLIC, by integrating cryo-electron microscopy and large-scale atomistic molecular dynamics simulations together with Markov state modeling. We identified 25 lipids in the closed state of GLIC - a conformation in which, to our knowledge, lipids have not been previously resolved. Both simulations and cryo-EM data predicted, for each subunit, three lipids in the inner leaflet and two in the outer leaflet. Further, we used simulations to make predictions about lipid interactions in the open state, resulting in six sites - three in each leaflet. Interactions of particular interest include one slow-exchanging interaction with a deeply buried lipid tail in the intersubunit space, where tail saturation levels played a role in the binding pose, and where the interaction could be broken due to a single mutation. An additional lipid interaction was preferential to the open state, potentially playing a role in stabilization of this state. This work provides molecular details of GLIC-lipid contacts, especially in the understudied closed state; a testable hypotheses for state-dependent binding; and a multidisciplinary strategy for modeling protein-lipid interactions.

Lipid Binding of SH2 Domains.

The Src homology 2 (SH2) domain is a modular protein interaction domain that specifically recognizes the phosphotyrosine (pY) motif of a target molecule. We recently reported that a large majority of human SH2 domains tightly bind membrane lipids, and many show high lipid specificity. Most of them can bind a lipid and the pY motif coincidently because their lipid-binding sites are topologically distinct from pY-binding pockets. Lipid binding of SH2 domain-containing kinases and phosphatases is functionally important because it exerts exquisite spatiotemporal control on protein-protein interaction and cell signaling activities mediated by these proteins. Here, we describe two assays, surface plasmon resonance analysis and fluorescence quenching analysis, which allow quantitative determination of the affinity and specificity of SH2-lipid interaction and high-throughput screening for SH2 domain-lipid-binding inhibitors.

Modulation of TRPV2 by endogenous and exogenous ligands: A computational study.

Transient receptor potential vanilloid (TRPV) channels play various important roles in human physiology. As membrane proteins, these channels are modulated by their endogenous lipid environment as the recent wealth of structural studies has revealed functional and structural lipid binding sites. Additionally, it has been shown that exogenous ligands can exchange with some of these lipids to alter channel gating. Here, we used molecular dynamics simulations to examine how one member of the TRPV family, TRPV2, interacts with endogenous lipids and the pharmacological modulator cannabidiol (CBD). By computationally reconstituting TRPV2 into a typical plasma membrane environment, which includes phospholipids, cholesterol, and phosphatidylinositol (PIP) in the inner leaflet, we showed that most of the interacting surface lipids are phospholipids without strong specificity for headgroup types. Intriguingly, we observed that the C-terminal membrane proximal region of the channel binds preferentially to PIP lipids. We also modelled two structural lipids in the simulation: one in the vanilloid pocket and the other in the voltage sensor-like domain (VSLD) pocket. The simulation shows that the VSLD lipid dampens the fluctuation of the VSLD residues, while the vanilloid lipid exhibits heterogeneity both in its binding pose and in its influence on protein dynamics. Addition of CBD to our simulation system led to an open selectivity filter and a structural rearrangement that includesa clockwise rotation of the ankyrin repeat domains, TRP helix, and VSLD. Together, these results reveal the interplay between endogenous lipids and an exogenous ligand and their effect on TRPV2 stability and channel gating.

Sublytic gasdermin-D pores captured in atomistic molecular simulations.

Gasdermin-D (GSDMD) is the ultimate effector of pyroptosis, a form of programmed cell death associated with pathogen invasion and inflammation. After proteolytic cleavage by caspases, the GSDMD N-terminal domain (GSDMDNT) assembles on the inner leaflet of the plasma membrane and induces the formation of membrane pores. We use atomistic molecular dynamics simulations to study GSDMDNT monomers, oligomers, and rings in an asymmetric plasma membrane mimetic. We identify distinct interaction motifs of GSDMDNT with phosphatidylinositol-4,5-bisphosphate (PI(4,5)P2) and phosphatidylserine (PS) headgroups and describe their conformational dependence. Oligomers are stabilized by shared lipid binding sites between neighboring monomers acting akin to double-sided tape. We show that already small GSDMDNT oligomers support stable, water-filled, and ion-conducting membrane pores bounded by curled beta-sheets. In large-scale simulations, we resolve the process of pore formation from GSDMDNT arcs and lipid efflux from partial rings. We find that high-order GSDMDNT oligomers can crack under the line tension of 86 pN created by an open membrane edge to form the slit pores or closed GSDMDNT rings seen in atomic force microscopy experiments. Our simulations provide a detailed view of key steps in GSDMDNT-induced plasma membrane pore formation, including sublytic pores that explain nonselective ion flux during early pyroptosis.

Structure and functionality of a multimeric human COQ7:COQ9 complex

Coenzyme Q (CoQ) is a redox-active lipid essential for core metabolic pathways and antioxidant defense. CoQ is synthesized upon the mitochondrial inner membrane by an ill-defined "complex Q" metabolon. Here, we present structure-function analyses of a lipid-, substrate-, and NADH-bound complex comprising two complex Q subunits: the hydroxylase COQ7 and the lipid-binding protein COQ9. We reveal that COQ7 adopts a ferritin-like fold with a hydrophobic channel whose substrate-binding capacity is enhanced by COQ9. Using molecular dynamics, we further show that two COQ7:COQ9 heterodimers form a curved tetramer that deforms the membrane, potentially opening a pathway for the CoQ intermediates to translocate from the bilayer to the proteins' lipid-binding sites. Two such tetramers assemble into a soluble octamer with a pseudo-bilayer of lipids captured within. Together, these observations indicate that COQ7 and COQ9 cooperate to access hydrophobic precursors within the membrane and coordinate subsequent synthesis steps toward producing CoQ.

The AAA+ ATPase RavA and its binding partner ViaA modulate E. coli aminoglycoside sensitivity through interaction with the inner membrane

Enteric bacteria have to adapt to environmental stresses in the human gastrointestinal tract such as acid and nutrient stress, oxygen limitation and exposure to antibiotics. Membrane lipid composition has recently emerged as a key factor for stress adaptation. The E. coli ravA-viaA operon is essential for aminoglycoside bactericidal activity under anaerobiosis but its mechanism of action is unclear. Here we characterise the VWA domain-protein ViaA and its interaction with the AAA+ ATPase RavA, and find that both proteins localise at the inner cell membrane. We demonstrate that RavA and ViaA target specific phospholipids and subsequently identify their lipid-binding sites. We further show that mutations abolishing interaction with lipids restore induced changes in cell membrane morphology and lipid composition. Finally we reveal that these mutations render E. coli gentamicin-resistant under fumarate respiration conditions. Our work thus uncovers a ravA-viaA-based pathway which is mobilised in response to aminoglycosides under anaerobiosis and engaged in cell membrane regulation.

Resolving the zinc binding capacity of honey bee vitellogenin and locating its putative binding sites.

The protein vitellogenin (Vg) plays a central role in lipid transportation in most egg-laying animals. High Vg levels correlate with stress resistance and lifespan potential in honey bees (Apis mellifera). Vg is the primary circulating zinc-carrying protein in honey bees. Zinc is an essential metal ion in numerous biological processes, including the function and structure of many proteins. Measurements of Zn2+ suggest a variable number of ions per Vg molecule in different animal species, but the molecular implications of zinc-binding by this protein are not well-understood. We used inductively coupled plasma mass spectrometry to determine that, on average, each honey bee Vg molecule binds 3 Zn2+ -ions. Our full-length protein structure and sequence analysis revealed seven potential zinc-binding sites. These are located in the β-barrel and α-helical subdomains of the N-terminal domain, the lipid binding site, and the cysteine-rich C-terminal region of unknown function. Interestingly, two potential zinc-binding sites in the β-barrel can support a proposed role for this structure in DNA-binding. Overall, our findings suggest that honey bee Vg bind zinc at several functional regions, indicating that Zn2+ -ions are important for many of the activities of this protein. In addition to being potentially relevant for other egg-laying species, these insights provide a platform for studies of metal ions in bee health, which is of global interest due to recent declines in pollinator numbers.

Dynamics of lipid displacement inside the hydrophobic cavity of a nonspecific lipid transfer protein from Solanum melongena

Nonspecific lipid transfer proteins are multifunctional and multispecific seed proteins with a characteristic hydrophobic cavity that runs form N-terminal to the C-terminal end. They are capable of binding and transferring different lipid molecules by means of their hydrophobic cavity. Apart from the cavity, lipid molecules bind and interact at key positions on the nsLTP surface as well. The plasticity of the hydrophobic cavity is an unusual property, considered as the primary lipid binding site. Here, we report a crystal structure of nsLTP from Solanum melongena with two lauric acid molecules bound inside the cavity. It has been observed that the extent of the N-terminal entry point and plasticity of the cavity can be extended, upon binding of one or two lipid molecules inside the cavity. The MD simulation further revealed that the lipid molecule shows high mobility inside the cavity and interestingly, was able to change its orientation. An alternate lipid entry site adjacent to the N-terminal end was uncovered during simulation and Arg-84 was implicated to be a potential regulatory residue aside from Tyr-59. Collectively, this study helps to understand that changes in orientation of the lipid inside the cavity could occur intermittently besides entering the cavity via tail-in-mechanism. Communicated by Ramaswamy H. Sarma

Insights into the C-terminal domain of apolipoprotein E from chimera studies with apolipophorin III.

Apolipoprotein E3 (apoE) is a critical cholesterol transport protein in humans and is composed of two domains: a well characterized N-terminal (NT) domain that harbors the low-density lipoprotein LDL receptor, and a less understood C-terminal (CT) domain that is the site of protein oligomerization and initiation of lipid binding. To better understand the domain structure of apoE, the CT domain was fused to apolipophorin III (apoLp-III), a single-domain, monomeric apolipoprotein of insect origin, to yield a chimeric protein, apoLp-III/CT-apoE. Recombinant apoLp-III/CT-apoE maintained an overall helical content similar to that of the parent proteins, while chemical induced unfolding studies indicated that its structural integrity was not compromised. Analysis using 1-anilinonaphthalene-8-sulfonic acid (ANS), a sensitive fluorescent indicator of exposed hydrophobic sites and protein folding, demonstrated that whereas apoLp-III provided few ANS binding sites, apoLp-III/CT-apoE harbored an abundance of ANS binding sites. Thus, this indicated tertiary structure formation in CT-apoE when part of the chimera. Size-exclusion chromatography and chemical crosslinking analysis demonstrated that while apoLp-III is monomeric, the chimeric protein formed large oligomeric complexes, similar to native apoE3. Compared to apoLp-III, the chimera showed a two-fold enhancement in phospholipid vesicle solubilization rates and a significantly improved ability to bind to lipolyzed low-density lipoprotein, preventing the onset of lipoprotein aggregation at concentrations comparable to that of parent CT-apoE. These results confirm that high lipid binding and self-association sites are located in the CT domain of apoE, and that these properties can be transferred to an unrelated apolipoprotein, demonstrating that these properties operate independently from the NT domain.